Zobrazeno 1 - 10
of 23
pro vyhledávání: '"J E, Schurig"'
Publikováno v:
Anticancer research. 12(3)
BMY-25551, 7-(2-hydroxyethoxy)mitosane, was selected from a series of mitomycin A (MMA) analogues for more detailed study. As with other members of this class, it was shown to be 8 to 20 times more potent than mitomycin C (MMC) in cytotoxicity to mur
Publikováno v:
Journal of medicinal chemistry. 33(8)
The antitumor and DNA-binding properties of a group of oligomeric platinum(II) and platinum(IV) complexes are described. The compounds, having the stoichiometry [cis-PtII(X)2(mu-OH)]2(NO3)2, where X is NH3, NH2CH2CH3, and NH2CH(CH3)2, were found to b
Publikováno v:
ChemInform. 21
Publikováno v:
Journal of medicinal chemistry. 33(1)
A series of platinum complexes of the form cis-M[PtA2(PC)] (I) has been prepared and tested for antitumor activity in mice. Compounds in this series contain either two monodentate amine ligands (A), such as NH3 or isopropylamine, or one bidentate dia
Publikováno v:
Clinical and Experimental Hypertension. 2:1039-1066
Subcutaneous administration of tiodazosin (0.1-3 mg/kg), prazosin (0.01-1 mg/kg), trimazosin (10-30 mg/kg) and phentolamine (0.1-3 mg/kg) to conscious spontaneously hypertensive rats (SHR) produced graded decreases in blood pressure with the order of
ChemInform Abstract: MITOMYCIN C AND PORFIROMYCIN ANALOGS WITH SUBSTITUTED ETHYLAMINES AT POSITION 7
Publikováno v:
Chemischer Informationsdienst. 14
Autor:
William A. Remers, S. M. Sami, S. E. Tarnow, J. E. Schurig, Bhashyam S. Iyengar, W. T. Bradner
Publikováno v:
Chemischer Informationsdienst. 15
Publikováno v:
Cancer treatment reports. 65(3-4)
The comparative pulmonary toxicity induced by bleomycin and talisomycin (former trivial name: tallysomycin A) was evaluated by measuring lung hydroxyproline content. Based on published subacute toxicity data, in which talisomycin was found to be four
Publikováno v:
Archives internationales de pharmacodynamie et de therapie. 233(2)
Butorphanol, levo-N-cyclobutylmethyl-3, 14beta-dihydroxy-morphinan, is a new agonist-antagonist type analgetic agent which is 4 times more potent than morphine in experimental animals. Equianalgetic doses of butorphanol and morphine were compared, fo
Publikováno v:
Experimental hematology. 13
An important objective of new anticancer drug discovery programs is identification of agents that are less myelosuppressive than those currently available. We have developed several animal models to evaluate these drugs for myelosuppression. Our scre